Form D · Pharmaceuticals
D&D Pharmatech Inc.
Seongnam Si, M5 · CIK 0002077939
Offering snapshot reported Aug 1, 2025 · SEC filing
- Reported sold
- $10.8M Offering amount: $10.8M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 1, 2025 | Initial | $10,800,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553476
Convertible Bonds
Source: Form D, filed Aug 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seol Heui Han | Director |
| Sunghoon Hong | Director, Executive |
| Seulki Lee | Director, Executive |
| Sungmook Lim | Director, Executive |
| Seungwon Lim | Director |
| Daehyun Shin | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4 Th Floor, 27, Geumto Ro 80 Beon Gil Sujeong Gu
Seongnam Si, M5, 13454
Phone: 82-31-8019-7771
Seongnam Si, M5, 13454
Phone: 82-31-8019-7771